Company
Leash Bio
Unleashing machine learning to solve medicinal chemistry
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Customers
- biopharma partners
Claim, correct or request removal
Record updated 20 September 2026
About
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of proteins to generate billions of data points, ideal for training advanced machine learning models.
Funding snapshot
- Total raised
- $9.3MSum of rounds, as of 2026-09-20Source (opens in a new tab)
- Latest round
- Seed, $9.3M2024-04-05
Funding rounds
- Seed
- $9.3M2024-04-05, Company stated
Loading relationship preview